Subjective biosafety assessment of bisdemethoxycurcumin from the rhizomes of Curcuma longa

References

• Ahmed T, Gilani AH. 2009. Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer’s disease. Pharmacol Biochem Behav. 91(4):554–559. doi: 10.1016/j.pbb.2008.09.010.
   PubMed Web of Science ®Google Scholar
• Chunekar KC. 2015. Bhavaprakasha Nighantu, Hindi commentary. Bhavamishra (edited from Bhavaprakasha Nighantu), editor. Varanasi: Chaukhambha Bharati Academy.
   Google Scholar
• Creager ANH. 2014. CHAPTER 2: the political life of mutagens: a history of the Ames test. In: Soraya B, Nathalie J, editors. Powerless science?: science and politics in a toxic world. New York (NY): Berghahn Books; p. 46–64. doi: 10.1515/9781782382379-005.
   Google Scholar
• Edwards RL, Luis PB, Nakashima F, Kunihiro AG, Presley S-H, Funk JL, Schneider C. 2020. Mechanistic differences in the inhibition of NF-κB by turmeric and its curcuminoid constituents. J Agric Food Chem. 68(22):6154–6160. doi: 10.1021/acs.jafc.0c02607.
   PubMed Web of Science ®Google Scholar
• He D, Chen S, Xiao Z, Wu H, Zhou G, Xu C, Chang Y, Li Y, Wang G, Xie M. 2020. Bisdemethoxycurcumin exerts a cell-protective effect via JAK2/STAT3 signaling in a rotenone-induced Parkinson’s disease model in vitro. Folia Histochem Cytobiol. 58(2):127–134. doi: 10.5603/FHC.a2020.0011.
   PubMed Web of Science ®Google Scholar
• Hua Y, Dolence J, Ramanan S, Ren J, Nair S. 2013. Bisdemethoxycurcumin inhibits PDGF‐induced vascular smooth muscle cell motility and proliferation. Mol Nutr Food Res. 57(9):1611–1618. doi: 10.1002/mnfr.201200852.
   PubMed Web of Science ®Google Scholar
• Jain R. 2020. Biological activities of bisdesmethoxycurcumin. J Nat Sci Med. 0(0):0. doi: 10.4103/JNSM.JNSM_65_19.
   Google Scholar
• Jin F, Chen X, Yan H, Xu Z, Yang B, Luo P, He Q. 2020. Bisdemethoxycurcumin attenuates cisplatin-induced renal injury through anti-apoptosis, anti-oxidant and anti-inflammatory. Eur J Pharmacol. 874:173026. doi: 10.1016/j.ejphar.2020.173026.
   PubMed Web of Science ®Google Scholar
• Jin F, Jin Y, Du J, Jiang L, Zhang Y, Zhao Z, Yang B, Luo P, He Q. 2019. Bisdemethoxycurcumin protects against renal fibrosis via activation of fibroblast apoptosis. Eur J Pharmacol. 847:26–31. doi: 10.1016/j.ejphar.2019.01.012.
   PubMed Web of Science ®Google Scholar
• Kulyal P, Kuchibhatla LN, Maheshwari KU, Babu KN, Tetali SD, Raghavendra AS. 2016. Highly sensitive HPLC method for estimation of total or individual curcuminoids in Curcuma cultivars and commercial turmeric powders. Curr Sci. 111(11):1816–1824. doi: 10.18520/cs/v111/i11/1816-1824.
   Web of Science ®Google Scholar
• Kunnumakkara AB, Hegde M, Parama D, Girisa S, Kumar A, Daimary UD, Garodia P, Yenisetti SC, Oommen OV, Aggarwal BB. 2023. Role of turmeric and curcumin in prevention and treatment of chronic diseases: lessons learned from clinical trials. ACS Pharmacol Transl Sci. 6(4):447–518. doi: 10.1021/acsptsci.2c00012.
   PubMedGoogle Scholar
• Liu J, Wang Q, Omari-Siaw E, Adu-Frimpong M, Liu J, Xu X, Yu J. 2020. Enhanced oral bioavailability of Bisdemethoxycurcumin-loaded self-microemulsifying drug delivery system: formulation design, in vitro and in vivo evaluation. Int J Pharm. 590:119887. doi: 10.1016/j.ijpharm.2020.119887.
   PubMed Web of Science ®Google Scholar
• Liu YL, Yang HP, Zhou XD, Gong L, Tang CL, Wang HJ. 2011. The hypomethylation agent bisdemethoxycurcumin acts on the WIF-1 promoter, inhibits the canonical Wnt pathway and induces apoptosis in human non-small-cell lung cancer. Curr Cancer Drug Targets. 11(9):1098–1110. doi: 10.2174/156800911798073041.
   PubMed Web of Science ®Google Scholar
• Mahattanadul S, Nakamura T, Panichayupakaranant P, Phdoongsombut N, Tungsinmunkong K, Bouking P. 2009. Comparative antiulcer effect of bisdemethoxycurcumin and curcumin in a gastric ulcer model system. Phytomedicine. 16(4):342–351. doi: 10.1016/j.phymed.2008.12.005.
   PubMed Web of Science ®Google Scholar
• Majeed M, Nagabhushanam K, Narayanan NK, Choudhury AK, Mundkur L, Nayak M, Thazhathidath S. 2019. Reductive metabolites of curcuminoids. Majeed M, Nagabhushanam K, editors. Piscataway (NJ): NutriScience Publishers, LLC.
   Google Scholar
• Matsunaga T, Endo S, Soda M, Zhao HT, El-Kabbani O, Tajima K, Hara A. 2009. Potent and selective inhibition of the tumor marker AKR1B10 by bisdemethoxycurcumin: probing the active site of the enzyme with molecular modeling and site directed mutagenesis. Biochem Biophys Res Commun. 389(1):128–132. doi: 10.1016/j.bbrc.2009.08.107.
   PubMed Web of Science ®Google Scholar
• [OECD] Organization for Economic Cooperation and Development. 2002. Test no. 423: acute oral toxicity – acute toxic class method, OECD guidelines for the testing of chemicals, section 4. Paris: OECD Publishing. doi: 10.1787/9789264071001-en.
   Google Scholar
• [OECD] Organization for Economic Cooperation and Development. 2008. Test no. 407: repeated dose 28-day oral toxicity study in rodents, OECD guidelines for the testing of chemicals, section 4. Paris: OECD Publishing. doi: 10.1787/9789264070684-en.
   Google Scholar
• [OECD] Organization for Economic Cooperation and Development. 2014. Test no. 474: mammalian erythrocyte micronucleus test. Paris: OECD Publishing. doi: 10.1787/9789264224292-en.
   Google Scholar
• [OECD] Organization for Economic Cooperation and Development. 2016. Test no. 421: reproduction/developmental toxicity screening test, OECD guidelines for the testing of chemicals, section 4. Paris: OECD Publishing. doi: 10.1787/9789264264380-en.
   Google Scholar
• [OECD] Organization for Economic Cooperation and Development. 2018. Test no. 408: repeated dose 90-day oral toxicity study in rodents, OECD guidelines for the testing of chemicals, section 4. Paris: OECD Publishing. doi: 10.1787/9789264070707-en.
   Google Scholar
• OECD. 2020. Test no. 471: bacterial reverse mutation test, OECD guidelines for the testing of chemicals, section 4. Paris: OECD Publishing. doi: 10.1787/9789264071247-en.
   Google Scholar
• Ponnusamy S, Zinjarde S, Bhargava S, Rajamohanan P, RaviKumar A. 2012. Discovering bisdemethoxycurcumin from Curcuma longa rhizome as a potent small molecule inhibitor of human pancreatic α-amylase, a target for type-2 diabetes. Food Chem. 135(4):2638–2642. doi: 10.1016/j.foodchem.2012.06.110.
   PubMed Web of Science ®Google Scholar
• Ramezani M, Hatamipour M, Sahebkar A. 2018. Promising anti-tumor properties of bisdemethoxycurcumin: a naturally occurring curcumin analogue. J Cell Physiol. 233(2):880–887. doi: 10.1002/jcp.25795.
   PubMed Web of Science ®Google Scholar
• Ramírez-Muñoz MP, Zúñiga G, Torres-Bugarín O, Portilla E, García-Martínez D, Ramos A, Cantú JM, Sánchez-Corona J. 1999. Evaluation of the micronucleus test in peripheral blood erythrocytes by use of the splenectomized model. Lab Anim Sci. 49(4):418–420.
   PubMedGoogle Scholar
• Revathy S, Elumalai S, Benny M, Antony B. 2011. Evaluation of curcuminoids in turmeric rhizome (Curcuma longa L.) collected from different places in India. Biosci Biotechnol Res Asia. 8(1):259–264. doi: 10.13005/bbra/853.
   Google Scholar
• Schlegel R, MacGregor JT. 1984. The persistence of micronucleated erythrocytes in the peripheral circulation of normal and splenectomized Fischer 344 rats: implications for cytogenetic screening. Mutat Res. 127(2):169–174. doi: 10.1016/0027-5107(84)90018-6.
   PubMedGoogle Scholar
• Sivabalan S, Anuradha C. 2010. A comparative study on the antioxidant and glucose-lowering effects of curcumin and bisdemethoxycurcumin analog through in vitro assays. Int J Pharmacol. 6(5):664–669. doi: 10.3923/ijp.2010.664.669.
   Google Scholar
• Sudeep VH, Gouthamchandra K, Chandrappa S, Naveen P, Reethi B, Venkatakrishna K, Shyamprasad K. 2021. In vitro gastrointestinal digestion of a bisdemethoxycurcumin-rich Curcuma longa extract and its oral bioavailability in rats. Bull Natl Res Cent. 45(1):84. doi: 10.1186/s42269-021-00544-8.
   Google Scholar
• Wang HJ, Yang ZX, Dai XT, Chen YF, Yang HP, Zhou XD. 2017. Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling. Apoptosis. 22(9):1157–1168. doi: 10.1007/s10495-017-1395-x.
   PubMed Web of Science ®Google Scholar
• Wei JX, Luo Y, Xu Y, Xiao JH. 2022. Osteoinductive activity of bisdemethoxycurcumin and its synergistic protective effect with human amniotic mesenchymal stem cells against ovariectomy-induced osteoporosis mouse model. Biomed Pharmacother. 146:112605. doi: 10.1016/j.biopha.2021.112605.
   PubMed Web of Science ®Google Scholar
• Widowati W, Wargasetia TL, Afifah E, Mozef T, Kusuma HSW, Nufus H, Arumwardana S, Amalia A, Rizal R. 2018. Antioxidant and antidiabetic potential of Curcuma longa and its compounds. Asian J Agric Biol. 6(2):149–161.
   Google Scholar
• Yang ST, Huang AC, Tang NY, Liu HC, Liao CL, Ji BC, Chou YC, Yang MD, Lu HF, Chung JG. 2016. Bisdemethoxycurcumin induced S phase arrest through the inhibition of cyclin A and E and induction of apoptosis via endoplasmic reticulum stress and mitochondria‐dependent pathways in human lung cancer NCI H 460 cells. Environ Toxicol. 31(12):1899–1908. doi: 10.1002/tox.22191.
   PubMed Web of Science ®Google Scholar
• Yodkeeree S, Chaiwangyen W, Garbisa S, Limtrakul P. 2009. Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down – regulation of MMPs and uPA. J Nutr Biochem. 20(2):87–95. doi: 10.1016/j.jnutbio.2007.12.003.
   PubMed Web of Science ®Google Scholar
• Yuan L, Lorenz H. 2018. Solvate formation of bis(imethoxy)curcumin: screening and characterization. Crystals. 8(11):407. doi: 10.3390/cryst8110407.
   Web of Science ®Google Scholar